US 8999976
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/538A61K31/5415
Quick answer
US patent 8999976 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/538, A61K31/5415, A61K45/06, A61P